Birrer M - Search Results

1

Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.

Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, Del Carmen MG, Rauh-Hain JA. Gockley A, et al. Among authors: birrer m. Obstet Gynecol. 2017 Mar;129(3):439-447. doi: 10.1097/AOG.0000000000001867. Obstet Gynecol. 2017. PMID: 28178043 Free PMC article.

2

Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.

Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Rauh-Hain JA, et al. Among authors: birrer mj. Int J Gynecol Cancer. 2013 Sep;23(7):1219-25. doi: 10.1097/IGC.0b013e31829f17c9. Int J Gynecol Cancer. 2013. PMID: 23975042

3

Variation in resource utilization associated with the surgical management of ovarian cancer.

Rauh-Hain JA, Hidrue MK, Gaccione P, Melamed A, Meyer LA, Keating NL, Giordano SH, Rice LW, Birrer MJ, Del Carmen MG. Rauh-Hain JA, et al. Gynecol Oncol. 2019 Mar;152(3):587-593. doi: 10.1016/j.ygyno.2018.12.013. Epub 2018 Dec 19. Gynecol Oncol. 2019. PMID: 30579568 Free PMC article.

4

Clear cell carcinoma of the ovary: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Among authors: birrer m. Gynecol Oncol. 2012 Sep;126(3):481-90. doi: 10.1016/j.ygyno.2012.04.021. Epub 2012 Apr 21. Gynecol Oncol. 2012. PMID: 22525820 Review.

5

Uterine papillary serous cancer: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Among authors: birrer m. Gynecol Oncol. 2012 Dec;127(3):651-61. doi: 10.1016/j.ygyno.2012.09.012. Epub 2012 Sep 20. Gynecol Oncol. 2012. PMID: 23000148 Review.

6

Advances in the management of recurrent endometrial cancer.

Bradford LS, Rauh-Hain JA, Schorge J, Birrer MJ, Dizon DS. Bradford LS, et al. Am J Clin Oncol. 2015 Apr;38(2):206-12. doi: 10.1097/COC.0b013e31829a2974. Am J Clin Oncol. 2015. PMID: 23764681 Review.

7

Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models.

Ye H, Tanenbaum LM, Na YJ, Mantzavinou A, Fulci G, Del Carmen MG, Birrer MJ, Cima MJ. Ye H, et al. Among authors: birrer mj. J Control Release. 2015 Dec 28;220(Pt A):358-367. doi: 10.1016/j.jconrel.2015.11.001. Epub 2015 Nov 5. J Control Release. 2015. PMID: 26548976

8

Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.

Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ. Del Carmen MG, et al. Among authors: birrer mj. Cancer. 2016 Nov 15;122(21):3297-3306. doi: 10.1002/cncr.30196. Epub 2016 Jul 15. Cancer. 2016. PMID: 27421044 Free article. Clinical Trial.

9

"Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities".

Rauh-Hain JA, Birrer M, Del Carmen MG. Rauh-Hain JA, et al. Among authors: birrer m. Gynecol Oncol. 2016 Aug;142(2):248-54. doi: 10.1016/j.ygyno.2016.06.003. Epub 2016 Jun 16. Gynecol Oncol. 2016. PMID: 27321238 Review.

10

Carcinosarcoma of the ovary: a review of the literature.

del Carmen MG, Birrer M, Schorge JO. del Carmen MG, et al. Among authors: birrer m. Gynecol Oncol. 2012 Apr;125(1):271-7. doi: 10.1016/j.ygyno.2011.12.418. Epub 2011 Dec 8. Gynecol Oncol. 2012. PMID: 22155675 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

529 results

Search Page